PIDSOG urges DOH to adopt 9-Valent HPV Vaccine

Q: How long will it take to read this news story?

The story "PIDSOG urges DOH to adopt 9-Valent HPV Vaccine" has 509 words across 21 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "PIDSOG urges DOH to adopt 9-Valent HPV Vaccine" was covered 12 hours ago by Business Mirror, a news publisher based in Philippines.

Q: How trustworthy is 'Business Mirror' news outlet?

Business Mirror is a fully independent (privately-owned) news outlet established in 2005 that covers mostly business and startups news. The outlet is headquartered in Philippines and publishes an average of 72 news stories per day. It's most recent story was published 19 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23683650</li><li>URL: https://beamstart.com/news/pidsog-urges-doh-to-adopt-17319789121500</li></ul>

Business Mirror Logo Business Mirror 12h ago

PIDSOG urges DOH to adopt 9-Valent HPV Vaccine - Business Mirror

Quick Summary:

The Philippine Infectious Diseases Society for Obstetrics and Gynecology (PIDSOG) is calling on the Department of Health (DOH) to incorporate the 9-valent human papillomavirus (HPV) vaccine into the Philippine National Immunization Program.

Widespread use of the vaccine “has the potential to significantly reduce the incidence of HPV-related cancers and diseases,” according to PIDSOG’s position paper.

The organization highlights that the “2-dose regimen has been proven to elicit a robust immune response in adolescents aged 9–14 years,” while for those aged 15 or older, or those with immunocompromising conditions, “the 3-dose regimen is preferred to ensure adequate immunogenicity and sustained antibody levels.